Dominik Heider

Prof. Dominik Heider

The Heiderlab, Department of Mathematics and Computer Science, University of Marburg, Hans-Meerwein-Str. 6, D-35032 Marburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Open access
JBJan Best
Jan Best
LBLars P. Bechmann
Lars P. Bechmann
JSJan-Peter Sowa
Jan-Peter Sowa
SSSvenja Sydor
Svenja Sydor
ADAlexander Dechêne
Alexander Dechêne
ACAli Canbay
Ali Canbay
The prevalence of nonalcoholic steatohepatitis (NASH) associated hepatocellular carcinoma (HCC) is increasing. However, strategies for detection of early-stage HCC in patients with NASH have limitations. We assessed the ability of the GALAD score, which determines risk of HCC based on patient sex; age; and serum levels of α-fetoprotein (AFP), AFP isoform L3 (AFP-L3), and des-gamma-carboxy prothrombin (DCP), to detect HCC in patients with NASH. We performed a case-control study of 125 patients with HCC (20% within Milan Criteria) and 231 patients without HCC (NASH controls) from 8 centers in Germany. We compared the performance of serum AFP, AFP-L3, or DCP vs GALAD score to identify patients with HCC using receiver operating characteristic curves and corresponding area under the curve (AUC) analyses. We also analyzed data from 389 patients with NASH under surveillance for HCC in Japan, followed for a median of 167 months. During the 5-year screening period, 26 patients developed HCC. To compensate for irregular intervals of data points, we performed locally weighted scatterplot smoothing, linear regression, and a non-linear curve fit to assess development of GALAD before HCC development. The GALAD score identified patients with any stage HCC with an AUC of 0.96 - significantly greater than values for serum levels of AFP (AUC, 0.88), AFP-L3 (AUC, 0.86) or DCP (AUC, 0.87). AUC values for the GALAD score were consistent in patients with cirrhosis (AUC, 0.93) and without cirrhosis (AUC, 0.98). For detection of HCC within Milan Criteria, the GALAD score achieved an AUC of 0.91, with a sensitivity of 68% and specificity of 95% at a cutoff of -0.63. In a pilot Japanese cohort study, the mean GALAD score was higher in patients with NASH who developed HCC than in those who did not develop HCC as early as 1.5 years before HCC diagnosis. GALAD scores were above -0.63 approximately 200 days before the diagnosis of HCC. In a case-control study performed in Germany and a pilot cohort study in Japan, we found the GALAD score may detect HCC with high levels of accuracy in patients with NASH, with and without cirrhosis. The GALAD score can detect patients with early-stage HCC, and might facilitate surveillance of patients with NASH, who are often obese, which limits the sensitivity of detection of liver cancer by ultrasound.

6 October 2021 in Bioinformatics
Verified
Journal Article
Open access
PDF file
YRYunxiao Ren
Yunxiao Ren
TCTrinad Chakraborty
Trinad Chakraborty
SDSwapnil Doijad
Swapnil Doijad
LFLinda Falgenhauer
Linda Falgenhauer
JFJane Falgenhauer
Jane Falgenhauer
Dominik HeiderDominik Heider
Dominik Heider
Antimicrobial resistance (AMR) is one of the biggest global problems threatening human and animal health. Rapid and accurate AMR diagnostic methods are thus very urgently needed. However, traditional antimicrobial susceptibility testing (AST) is time-consuming, low throughput and viable only for cultivable bacteria. Machine learning methods may pave the way for automated AMR prediction based on genomic data of the bacteria. However, comparing different machine learning methods for the prediction of AMR based on different encodings and whole-genome sequencing data without previously known knowledge remains to be done. In this study, we evaluated logistic regression (LR), support vector machine (SVM), random forest (RF) and convolutional neural network (CNN) for the prediction of AMR for the antibiotics ciprofloxacin, cefotaxime, ceftazidime and gentamicin. We could demonstrate that these models can effectively predict AMR with label encoding, one-hot encoding and frequency matrix chaos game representation (FCGR encoding) on whole-genome sequencing data. We trained these models on a large AMR dataset and evaluated them on an independent public dataset. Generally, RFs and CNNs perform better than LR and SVM with AUCs up to 0.96. Furthermore, we were able to identify mutations that are associated with AMR for each antibiotic. Source code in data preparation and model training are provided at GitHub website (https://github.com/YunxiaoRen/ML-iAMR). Supplementary data are available at Bioinformatics online.

29 May 2007 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
Dominik HeiderDominik Heider
Dominik Heider
ABAngelika Barnekow
Angelika Barnekow
The aim of this paper is to demonstrate the application of watermarks based on DNA sequences to identify the unauthorized use of genetically modified organisms (GMOs) protected by patents. Predicted mutations in the genome can be corrected by the DNA-Crypt program leaving the encrypted information intact. Existing DNA cryptographic and steganographic algorithms use synthetic DNA sequences to store binary information however, although these sequences can be used for authentication, they may change the target DNA sequence when introduced into living organisms.

9 February 2016 in The ISME Journal
Verified
Journal Article
Open access
PDF file
LGLars Grossmann
Lars Grossmann
MJManfred Jensen
Manfred Jensen
Dominik HeiderDominik Heider
Dominik Heider
SJSteffen Jost
Steffen Jost
EGEdvard Glücksman
Edvard Glücksman
JBJens Boenigk
Jens Boenigk
Protists are perhaps the most lineage-rich of microbial lifeforms, but remain largely unknown. High-throughput sequencing technologies provide opportunities to screen whole habitats in depth and enable detailed comparisons of different habitats to measure, compare and map protistan diversity. Such comparisons are often limited by low sample numbers within single studies and a lack of standardisation between studies. Here, we analysed 232 samples from 10 sampling campaigns using a standardised PCR protocol and bioinformatics pipeline. We show that protistan community patterns are highly consistent within habitat types and geographic regions, provided that sample processing is standardised. Community profiles are only weakly affected by fluctuations of the abundances of the most abundant taxa and, therefore, provide a sound basis for habitat comparison beyond random short-term fluctuations in the community composition. Further, we provide evidence that distribution patterns are not solely resulting from random processes. Distinct habitat types and distinct taxonomic groups are dominated by taxa with distinct distribution patterns that reflect their ecology with respect to dispersal and habitat colonisation. However, there is no systematic shift of the distribution pattern with taxon abundance.

5 October 2024 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
OSOluwafemi A. Sarumi
Oluwafemi A. Sarumi
Dominik HeiderDominik Heider
Dominik Heider
Recent advancements in Natural Language Processing (NLP) have been significantly driven by the development of Large Language Models (LLMs), representing a substantial leap in language-based technology capabilities. These models, built on sophisticated deep learning architectures, typically transformers, are characterized by billions of parameters and extensive training data, enabling them to achieve high accuracy across various tasks. The transformer architecture of LLMs allows them to effectively handle context and sequential information, which is crucial for understanding and generating human language. Beyond traditional NLP applications, LLMs have shown significant promise in bioinformatics, transforming the field by addressing challenges associated with large and complex biological datasets. In genomics, proteomics, and personalized medicine, LLMs facilitate identifying patterns, predicting protein structures, or understanding genetic variations. This capability is crucial, e.g., for advancing drug discovery, where accurate prediction of molecular interactions is essential. This review discusses the current trends in LLMs research and their potential to revolutionize the field of bioinformatics and accelerate novel discoveries in the life sciences.

1 September 2019 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
SSSebastian Spänig
Sebastian Spänig
AEAgnes Emberger-Klein
Agnes Emberger-Klein
JSJan-Peter Sowa
Jan-Peter Sowa
ACAli Canbay
Ali Canbay
KMKlaus Menrad
Klaus Menrad
Dominik HeiderDominik Heider
Dominik Heider